Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
---|
10/17/2012 | CN102727641A External traditional Chinese medicine for treating superficial phlebitis |
10/17/2012 | CN102727629A Method for extracting biological flavonoid by using citrus waste residues |
10/17/2012 | CN102727627A Traditional Chinese medicine composition for treating heart failure and preparation method and application thereof |
10/17/2012 | CN102727617A Chinese medicinal composition for treating hypertension |
10/17/2012 | CN102727608A Nadolol-apple seed oil nanoemulsion antihypertensive drug |
10/17/2012 | CN102727600A Traditional Chinese medicinal composition for treating heart failure, and preparation method and application thereof |
10/17/2012 | CN102727588A Hemorrhoid medicine prepared by using pure traditional Chinese medicines, and preparation method thereof |
10/17/2012 | CN102727587A Puffed Spica Prunellae, mulberry leaf and chrysanthemum granule, and preparation method thereof |
10/17/2012 | CN102727584A Method for extracting flavonoids from camphor tree leaves |
10/17/2012 | CN102727582A Red sage root extract-containing injection and preparation method thereof |
10/17/2012 | CN102727576A Tongmai puffed granules and preparation method of same |
10/17/2012 | CN102727575A Medicine for treating hypertension, hyperlipidemia and hyperglycemia and preparation method of medicine |
10/17/2012 | CN102727570A External pharmaceutical composition for treating diabetic foot as well as preparation method and application of external pharmaceutical composition |
10/17/2012 | CN102727561A Watermelon frost traditional Chinese medicine compound preparation and purpose |
10/17/2012 | CN102727548A New technology and method for extracting ginseng stem and leaf total saponin |
10/17/2012 | CN102727546A Health-promoting composition for treating insomnia and cardiovascular/cerebrovascular diseases |
10/17/2012 | CN102727540A Method for preparing red bayberry leaf extract |
10/17/2012 | CN102727538A Process for extracting ginkgo biloba flavone, ginkgo biloba lactone and ginkgo biloba phenolic acid from ginkgo biloba leaves |
10/17/2012 | CN102727536A Metasequoia glyptostroboides bark extract, preparation method thereof and uses thereof |
10/17/2012 | CN102727530A Combination and application of probiotics and related prebiotics |
10/17/2012 | CN102727528A Hemorrhoid treatment medicine and its preparation method |
10/17/2012 | CN102727511A Chinese medicinal active component composite for vasodilation |
10/17/2012 | CN102727501A Uses of sapogenins and their derivatives |
10/17/2012 | CN102727500A Compound aminophylline rapidly disintegrating oral tablet |
10/17/2012 | CN102727486A Application of Inula lineariifolia lactone A in preparation of medicine for treating myocarditis |
10/17/2012 | CN102727482A Daidzein-hydroxypropyl-beta-cyclodextrin clathrate and its preparation method |
10/17/2012 | CN102727481A Medicinal composition containing levocarnitine and hydroxyphenyl sulfonate |
10/17/2012 | CN102727479A Application of retinoic acid and its derivatives in preparation of drugs preventing and treating atherosclerosis |
10/17/2012 | CN102727460A Slow-release tablets containing felodipine and metoprolo salt, and preparation method thereof |
10/17/2012 | CN102727441A Captopril-carrying nano-grade fiber sustained-release system and preparation method thereof |
10/17/2012 | CN102727431A Injecta containing milrinone and preparation method thereof |
10/17/2012 | CN102727428A Preparation method of muscular amino acids and nucleosides injection |
10/17/2012 | CN102311432B Stable vinpocetine compound and pharmaceutical composition thereof |
10/17/2012 | CN102258693B Traditional Chinese medicine for treating hypertension |
10/17/2012 | CN102240340B Method for processing prepared rehmannia root |
10/17/2012 | CN102240294B Medicament composition, and preparation and application thereof |
10/17/2012 | CN102188468B Preparation method of Xinnaoshutong tablet |
10/17/2012 | CN102048685B Pefloxacin mesylate injection and preparation method and application thereof |
10/17/2012 | CN101967195B Thrombolysis-targeting fusion protein mAnxB1ScuPA, structure and application thereof |
10/17/2012 | CN101879274B Medicine composition containing red ginseng saponin extract and radix ophiopogonis saponin extract as well as preparation method and application thereof |
10/17/2012 | CN101851237B spiro compounds, method for preparing same and application thereof |
10/17/2012 | CN101653548B Chinese medicinal composition in preparation of medicament for treating hypotension |
10/17/2012 | CN101584842B Medicament for treating coronary disease, angina pectoris and reducing blood fat, blood sugar, and preparation method thereof |
10/17/2012 | CN101536988B Troxerutin freeze-dried powder injection and preparation method thereof |
10/17/2012 | CN101316839B Acid addition salt of dihydropyridine derivative |
10/17/2012 | CN101316608B Bacillus subtilis novel bacterial strain and usage thereof in preparation of medicament for treating thrombus disease |
10/17/2012 | CN101247822B EPO derivative-containing therapeutic agents for blood-related diseases |
10/17/2012 | CN101220064B Novel scutellaria glycosides compounds and uses thereof |
10/16/2012 | US8288540 2-heteroarylamino-pyrimidine derivatives as kinase inhibitors |
10/16/2012 | US8288537 Caspase inhibitors and uses thereof |
10/16/2012 | US8288368 inhibitors of the C5a induced chemotaxis; psoriasis, ulcerative cholitis, glomerular nephritis, acute respiratory insufficiency, idiopathic fibrosis, rheumatoid arthritis and in the prevention and the treatment of injury caused by ischemia and reperfusion |
10/16/2012 | US8288338 Exendin and exendin agonists for eating disorders |
10/16/2012 | US8287873 Vascular endothelial cell growth factor antagonists and uses thereof |
10/16/2012 | CA2683341C Hemorrhoid treatment pad |
10/16/2012 | CA2485681C Ccr9 inhibitors and methods of use thereof |
10/16/2012 | CA2466773C Inhibitor oligonucleotides and their use for specific repression of a gene |
10/16/2012 | CA2368357C Methods for treating congestive heart failure |
10/16/2012 | CA2356257C Insulin-like growth factor (igf) i mutant variants |
10/11/2012 | WO2012138880A2 Methods of treating inflammatory diseases by targeting the chemoattractant cytokine receptor 2 (ccr2) or chemokine (c-c motif) ligand 2 (ccl2) |
10/11/2012 | WO2012138797A1 3- or 5 - bi phenyl - 4 - ylisoxazole - based compounds useful for the treatment of fibrosis, pain, cancer and respiratory, allergic, nervous system or cardiovascular disorders |
10/11/2012 | WO2012138706A1 Epoxyeicosatrienoic acid analogs and methods of making and using the same |
10/11/2012 | WO2012138648A1 Compositions and methods for modulating lpa receptors |
10/11/2012 | WO2012138341A1 Controlled delivery of molecules from a biointerface |
10/11/2012 | WO2012138226A1 Beta-guanidinopropionic acid for the treatment of hypertension |
10/11/2012 | WO2012138214A1 Beta-guanidinopropionic acid for the treatment of hypertension |
10/11/2012 | WO2012138213A1 Reduction of vascular dysfunction with specific saccharides |
10/11/2012 | WO2012138147A2 1-(3-cyano-1-isopropyl-indol-5-yl)pyrazole-4-carboxylic acid crystalline form and the producing method thereof |
10/11/2012 | WO2012138043A2 Therapeutic composition containing endothelin as an active component |
10/11/2012 | WO2012136443A1 Endothelial progenitor cells labelled with superparamagnetic iron oxide micro and nanoparticles in cerebrovascular disorders, process for their preparation and uses thereof |
10/11/2012 | WO2012136111A1 Phenylpropionic acid compound, preparation method therefor and medicinal use thereof |
10/11/2012 | WO2012125957A9 Methods and materials for reducing venous stenosis formation of an arteriovenous fistula or graft |
10/11/2012 | WO2012046008A3 Inhibitors of pde4 binding to hsp20 |
10/11/2012 | US20120259151 Pyridopyrazine derivatives and their use |
10/11/2012 | US20120259022 Pharmaceutical compositions providing enhanced drug concentrations |
10/11/2012 | US20120258997 New application of 2-pyrrolidone derivatives |
10/11/2012 | US20120258996 Novel ligands that modulate rar receptors |
10/11/2012 | US20120258987 Lysophosphatidic acid receptor antagonists |
10/11/2012 | US20120258986 Olefin containing nuclear transport modulators and uses thereof |
10/11/2012 | US20120258982 Adamantyl compounds |
10/11/2012 | US20120258981 Process for the Synthesis of Quaternary Amine Compounds |
10/11/2012 | US20120258978 Nitrogen-containing six-membered aromatic ring derivatives and pharmaceutical products containing the same |
10/11/2012 | US20120258974 Use of a2b adenosine receptor antagonists for treating heart failure and arrhythmia in post-myocardial infarction patients |
10/11/2012 | US20120258968 4-phenylamino-pyrimidine derivatives having protein kinase inhibitor activity |
10/11/2012 | US20120258967 Pi3 kinase inhibitors and uses thereof |
10/11/2012 | US20120258965 N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors |
10/11/2012 | US20120258962 1,3-oxazines as bace1 and/or bace2 inhibitors |
10/11/2012 | US20120258960 Novel multifunctional peptidase inhibitors, especially for medical use |
10/11/2012 | US20120258959 Pyridone gpr119 g protein-coupled receptor agonists |
10/11/2012 | US20120258954 ArylSulfonamide Based Matrix Metalloprotease Inhibitors |
10/11/2012 | US20120258952 Substituted N-(1H-Indazol-4-yl)Imidazo[1,2-a]Pyridine-3-Carboxamide Compounds as cFMS Inhibitors |
10/11/2012 | US20120258951 Novel antiplatelet agent |
10/11/2012 | US20120258949 Spirocyclic derivatives as histone deacetylase inhibitors |
10/11/2012 | US20120258938 Enzymatic Production or Chemical Synthesis and Uses for 5,7-Dienes and UVB Conversion Products Thereof |
10/11/2012 | US20120258932 Combination of polychitosamine and hmg-coa reductase inhibitor for hyperlipidemia |
10/11/2012 | US20120258927 Inhibitors of e1 activating enzymes |
10/11/2012 | US20120258926 Formulations of acadesine |
10/11/2012 | US20120258917 Peripheral Administration of Proteins Including TGF-beta Superfamily Members for Treatment of Systemic Disorders and Disease |
10/11/2012 | US20120258911 Phenylalkylcarboxylic acid delivery agents |
10/11/2012 | US20120258905 Vitamin receptor drug delivery conjugates for treating inflammation |
10/11/2012 | US20120258170 Pharmaceutical co-crystals of quercetin |